A research team led by investigators from the National Institutes of Health and Global Good has developed a computer algorithm that can analyze digital images of a woman’s cervix and accurately identify precancerous changes that require medical attention.
This artificial intelligence (AI) approach, called automated visual evaluation, has the potential to revolutionize cervical cancer screening, particularly in low-resource settings.
To develop the method, researchers used comprehensive datasets to “train” a deep, or machine, learning algorithm to recognize patterns in complex visual inputs, such as medical images. The approach was created collaboratively by investigators at the National Cancer Institute (NCI) and Global GoodExit Disclaimer, a fund at Intellectual Ventures, and the findings were confirmed independently by experts at the National Library of Medicine (NLM). The results appeared in the Journal of the National Cancer Institute on January 10, 2019. NCI and NLM are parts of NIH.
“Our findings show that a deep learning algorithm can use images collected during routine cervical cancer screening to identify precancerous changes that, if left untreated, may develop into cancer,” said Mark Schiffman, M.D., M.P.H., of NCI’s Division of Cancer Epidemiology and Genetics, and senior author of the study. “In fact, the computer analysis of the images was better at identifying precancer than a human expert reviewer of Pap tests under the microscope (cytology).”
The new method has the potential to be of particular value in low-resource settings. Health care workers in such settings currently use a screening method called visual inspection with acetic acid (VIA). In this approach, a health worker applies dilute acetic acid to the cervix and inspects the cervix with the naked eye, looking for “aceto whitening,” which indicates possible disease. Because of its convenience and low cost, VIA is widely used where more advanced screening methods are not available. However, it is known to be inaccurate and needs improvement.
Automated visual evaluation is similarly easy to perform. Health workers can use a cell phone or similar camera device for cervical screening and treatment during a single visit. In addition, this approach can be performed with minimal training, making it ideal for countries with limited health care resources, where cervical cancer is a leading cause of illness and death among women.
To create the algorithm, the research team used more than 60,000 cervical images from an NCI archive of photos collected during a cervical cancer screening study that was carried out in Costa Rica in the 1990s. More than 9,400 women participated in that population study, with follow up that lasted up to 18 years. Because of the prospective nature of the study, the researchers gained nearly complete information on which cervical changes became precancers and which did not. The photos were digitized and then used to train a deep learning algorithm so that it could distinguish cervical conditions requiring treatment from those not requiring treatment.
Overall, the algorithm performed better than all standard screening tests at predicting all cases diagnosed during the Costa Rica study. Automated visual evaluation identified precancer with greater accuracy (AUC=0.91) than a human expert review (AUC=0.69) or conventional cytology (AUC=0.71). An AUC of 0.5 indicates a test that is no better than chance, whereas an AUC of 1.0 represents a test with perfect accuracy in identifying disease.
“When this algorithm is combined with advances in HPV vaccination, emerging HPV detection technologies, and improvements in treatment, it is conceivable that cervical cancer could be brought under control, even in low-resource settings,” said Maurizio Vecchione, executive vice president of Global Good.
The researchers plan to further train the algorithm on a sample of representative images of cervical precancers and normal cervical tissue from women in communities around the world, using a variety of cameras and other imaging options. This step is necessary because of subtle variations in the appearance of the cervix among women in different geographic regions. The ultimate goal of the project is to create the best possible algorithm for common, open use.
The Latest on: Cervical cancer
via Google News
The Latest on: Cervical cancer
- PDS Biotech initiates study of lead oncology drug in cervical canceron June 4, 2020 at 6:14 pm
(NASDAQ:PDSB) announces plans for a Phase 2 clinical trial evaluating lead oncology candidate PDS0101, combined with standard-of-care chemo, in patients with locally advanced cervica ...
- At-home cervical cancer tests piloted in Dumfries and Gallowayon June 4, 2020 at 8:53 am
A new study is taking place at the Dumfries and Galloway Royal Infirmary that is investigating the feasibility of home testing kits for cervical cancer. They have already proved to be a success in ...
- PDS Biotech Announces Clinical Trial of Its Lead Immunotherapy Product, PDS0101, in Combination with Chemoradiotherapy in Advanced Cervical Canceron June 4, 2020 at 7:05 am
PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune ® ...
- Global Cervical Cancer Treatment Market 2020 Opportunities, Key Players, Segmentation, Trend and Forecast by 2026on June 3, 2020 at 9:11 pm
A report added to the rich database of MarketsandResearch.biz, titled Global Cervical Cancer Treatment Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 is aimed at ...
- Married At First Sight: Vanessa Romito reveals cervical cancer battleon June 3, 2020 at 2:09 pm
Married At First Sight's Vanessa Romito was diagnosed with cervical cancer at 21. The 31-year-old discussed her battle with the deadly disease with fans on Instagram on Wednesday, revealing she was ...
- Breast and cervical cancer screenings down due to COVID-19, doctors warn of cancer spikeon June 3, 2020 at 4:05 am
Both mammogram and cervical cancer screenings have declined since COVID-19 started in part because they fell under elective procedures that were temporarily canceled during stay-home orders across ...
- Applying Serum Proteins and MicroRNA as Novel Biomarkers for Early-Stage Cervical Cancer Detectionon June 3, 2020 at 2:12 am
Recently, we have been seeing emerging applications of non-invasive approaches using serum biomarkers including miRNA and proteins in detection of multiple cancers. Currently, majority of these ...
- Cervical cancer vaccine boost increases supply for up to 84 million girls worldwideon June 3, 2020 at 2:00 am
At least 84 million girls living in some of the world’s poorest countries will now have access to a vaccine which prevents cervical cancer after five drug manufacturers committed to boost global ...
- Cervical Cancer Therapeutics Market 2020-2024 | Increasing Prevalence Of Cervical Cancer to Boost Growth | Technavioon May 29, 2020 at 9:00 am
Technavio has been monitoring the cervical cancer therapeutics market and it is poised to grow by $1.06 bn during 2020-2024, progressing at a CAGR of about 7% during the forecast period. The report ...
- Global Cervical Cancer Diagnostics and Therapeutics Market 2020- 2025 - ResearchAndMarkets.comon May 29, 2020 at 2:01 am
The "Cervical Cancer Diagnostics and Therapeutics Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The factors propelling the growth of ...
via Bing News